Member States and marketing authorisation holders shall use the formats provided for in Article 26 and the terminology provided for in Article 25 for the electronic transmission of suspected adverse reactions.
Art. 29 Commission Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance o…
Format of electronic transmission of suspected adverse reactions
In forcesince 19 Jun 2012